SAVELINER 800 is a trusted phosphate-binding medication containing Sevelamer 800 mg, widely prescribed for the management of hyperphosphatemia (elevated phosphate levels in blood) in patients with chronic kidney disease (CKD), especially those undergoing dialysis. In individuals with impaired kidney function, excess phosphate is not effectively eliminated from the body, leading to complications affecting bones, blood vessels, and the cardiovascular system.
Sevelamer is a non-calcium, non-metal phosphate binder that works within the gastrointestinal tract. It binds dietary phosphate from food and prevents its absorption into the bloodstream. By controlling serum phosphate levels without increasing calcium load, SAVELINER 800 helps maintain mineral balance and reduces the risk of long-term complications associated with CKD.
Uses
SAVELINER 800 is indicated for:
Treatment of hyperphosphatemia in patients with chronic kidney disease
Phosphate control in patients undergoing hemodialysis or peritoneal dialysis
Prevention of bone disorders related to mineral imbalance
Reduction of vascular and soft tissue calcification risk
This medicine is typically prescribed along with a low-phosphate diet and regular monitoring as part of a comprehensive renal care program.
Benefits
SAVELINER 800 provides several important therapeutic benefits:
Effective Phosphate Control: Binds excess dietary phosphate efficiently
Calcium-Free Formula: Minimizes the risk of hypercalcemia
Protects Bone Health: Helps prevent renal osteodystrophy
Supports Cardiovascular Health: Reduces phosphate-related vascular calcification
Suitable for Long-Term Use: Can be safely used under medical supervision
Improves Patient Outcomes: Supports better mineral metabolism management
By maintaining optimal phosphate levels, SAVELINER 800 helps improve quality of life for patients with chronic kidney disease.
Dosage
The dosage of SAVELINER 800 must be individualized based on serum phosphate levels, dietary intake, and dialysis status.
Initial Dose: Usually 800 mg taken with each meal
Dose Adjustment: Based on regular serum phosphate monitoring
Administration: Tablets should be swallowed whole with water and taken during meals
Missed Dose: Skip the missed dose if the next meal dose is due; do not double the dose
Strict adherence to the prescribed dosing schedule ensures effective phosphate control.
Side Effects
Most patients tolerate SAVELINER 800 well. However, some may experience gastrointestinal side effects such as:
Nausea or vomiting
Constipation or diarrhea
Abdominal pain or bloating
Indigestion
Rare but serious side effects include:
Intestinal obstruction
Severe gastrointestinal discomfort
Difficulty swallowing
If severe or persistent symptoms occur, seek immediate medical attention.
Precautions and Warning
Gastrointestinal Conditions: Use with caution in patients with bowel obstruction or severe constipation
Drug Interactions: Sevelamer may reduce absorption of certain medicines; maintain proper time intervals as advised
Vitamin Deficiency: Long-term use may reduce absorption of fat-soluble vitamins (A, D, E, K); supplementation may be necessary
Pregnancy & Breastfeeding: Use only under medical supervision
Monitoring: Regular blood tests to monitor phosphate, calcium, and vitamin levels are recommended
Always inform your doctor about all medications and supplements being taken.
Conclusion
SAVELINER 800 Sevelamer 800 mg is an essential component in the management of hyperphosphatemia in patients with chronic kidney disease. Its calcium-free phosphate-binding action helps protect bones, reduce cardiovascular risks, and maintain mineral balance without increasing calcium burden.
When used as part of a comprehensive renal care plan that includes dietary management and regular monitoring, SAVELINER 800 supports improved clinical outcomes and better quality of life for CKD patients. Always follow medical advice to ensure safe and effective use.
